Cordlife (SGX: P8A)

Public holiday for Singapore - Public holiday in lieu


+0.015 (+4.48%)
Range 0.330 - 0.350   (6.06%)
Open 0.330
Previous Close 0.335
Buy Price 0.330
Buy Volume 11.3
Sell Price 0.350
Sell Volume 7.1
Volume 60.1
Value 19,835
Measurement Type Value
EPS (SGD) 0.025
Trailing EPS (SGD) 0.025
NAV (SGD) 0.507
Cash In Hand (SGD) 0.058
Dividend 0.01
Dividend Yield (%) 2.851
PE 13.769
Trailing PE 13.77
Price / NAV 0.69
Price / Cash In Hand 6.024
Issued & Paid-up Shares 254,583,000
Treasury Shares 12,943,000
Market Cap (M) 89.104
Par Value (SGD) n.a.
Beta - 75 Days 0.282
R-Squared - 75 Days(%) 0.8
Beta - 500 Days 0.876
R-Squared - 500 Days(%) 7.02
ISIN Code SG2E64980112
Under CPF Investment Scheme (CPFIS) Yes
Index Components FTSE ST Fledgling
Delayed prices. Updated at 07 Aug 2020 17:16.
Data powered by
View All Events

About Cordlife

Cordlife Group Limited is an investment holding company engaged in the provision of cord blood banking services, which involves the processing and storage of stem cells. The Company operates as a consumer healthcare company. Its segments include Banking, Diagnostic and Others. The banking segment comprises cord blood and cord lining services. The diagnostics segment comprises Metascreen, which is a metabolic screening test specially designed for newborn babies, non-invasive prenatal testing service, and Eyescreen, a noninvasive pediatric eye-screening service. The cord blood and cord lining are collected, processed and stored in the various laboratories in the regions that the Company operates in. The Company also releases cord blood units for transplants, and for the treatment of cerebral palsy, as well as for other therapeutic uses. It has processing and cryopreservation storage facilities across Asia, namely in Singapore, Hong Kong, India, Indonesia, Malaysia and the Philippines.

Loading Chart...